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Antibody-antigen complexes bind to the surface of some mouse lymphocytes 
(1-2).  Recent evidence has suggested that this property may be characteristic 
of  some  nonthymus-derived  "B"  lymphocytes:  (3),  not  of  thymus-derived 
"T"  lymphocytes (4).  A  similar conclusion has been reached independently in 
our  laboratory  from  studies  originally designed  to  examine  the  relationship 
between  antigen-binding  cells  and  "memory"  cells in  primed mice.  In  these 
experiments,  use  was  made  of  the  sensitive  technique  of radioautography  to 
establish  the  presence  of  a  receptor  for  antibody  on  lyrnphocytes.  Thoracic 
duct  lymphocytes  (TDL)  were  selected as  the main  source  of lymphoid cells 
because of their high viability and low contamination with other cell types. 
The identity of lymphocytes binding antibody was established by examina- 
tion of cell populations either enriched for T  cells or B  cells or containing the 
two cell types in known numbers. The T  cell content was assessed by means of 
independent genetic markers such as 0 C3H  antigen or H-2 antigen in the case 
of chimeric mice. When this figure was compared with the proportion of anti- 
body-binding  lymphocytes,  an  inverse  relationship  was  observed.  An  exact 
correlation  was  therefore  demonstrable  between  the  number  of  lymphocytes 
binding antibody and the number of B  cells in the population. In other words, 
the  receptor is  carried  by  all B  cells,  not  by just  a  subclass of  B  cells. The 
identification of a marker of this kind on all B  cells has permitted the develop- 
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ment  of  a  technique  for  separating  T  cells  from  B  cells  on  antigen-coated 
columns  (5). 
The  mechanism  of  attachment  of  antibody  to  receptor  will  be discussed  in 
the subsequent  paper  (6).  Although  the binding process required  an intact Fc 
piece,  it  was  apparently  complement  independent.  The  conclusion is  reached 
that  the  antibody-binding  receptor  and  antigen-binding  (immunoglobulin) 
receptor on B  lymphocytes  are distinct entities. 
Materials and Methods 
Animals.--Male and female mice of the highly inbred CBA strain and the (CBA X  C57BL) 
Ft hybrid were used in the majority of the experiments. Their origin and maintenance have 
been described previously (7). Athymic mice (nude; nu/nu) were obtained originally from the 
McMaster  Laboratory,  Commonwealth  Scientific  and  Industrial  Research  Organization, 
Sydney, and maintained subsequently at the Hall Institute by Dr. M. Holmes. 
Operative Procedures.--Thoracic duct cannulation was carried out by the method of Miller 
and Mitchell (7). Lymph was collected from each mouse at 4°C into 2 ml of Dulbeeco's phos- 
phate-buffered saline (8) containing 10% fetal calf serum (FCS)  (Commonwealth Serum Lab- 
oratories, Melbourne, Australia) with 50-100 IU of preservative-free hepariu  (Evans Medical 
Ltd.,  Liverpool, England). Thymectomy was performed in young adult CBA mice, 4-7 wk 
old, as described by Miller (9). The mediastinum was examined at autopsy and any mice with 
thymus remnants discarded. 
Preparation of Cell Suspensions.--Single  cell suspensions of thymus, spleen, lymph nodes, 
and Payer's patches were obtained by teasing the tissues through an 80 mesh stainless steel 
sieve in cold Eisen's solution (10).  The cells were washed twice in the case of spleen,  lymph 
nodes, and Payer's patches and three times for thymus. Bone marrow cells were expressed from 
the femurs of mice  by a  syringe and attached needle containing cold  Eisen's  solution and 
washed once before counting. 
TDL were collected as described previously. To wash them before incubation with iodinated 
antigen, suspensions were centrifuged through FCS gradients as described by Byrt and Ada 
(11). Lymphocytes were obtained from peripheral blood by sedimentation of heparinized sam- 
ples on a methylcellulose-Urographin gradient as described by Hulliger and Blazhovec (12). 
They were washed three times before use. 
lrradlation.--Intact  or thymectomized mice were exposed  to  total body  irradiation in a 
Philips (RT 250) X-ray machine (Philips Electronic Instruments, Mount Vernon, N.Y.). The 
dose used was 750-800 rads to midpoint with maximum back scatter at 15 ma and a half-value 
layer of 0.8 mm copper. Cell suspensions were injected within 3 hr of irradiation. In the case 
of thymectomized mice, irradiation was performed 2-4 wk postoperatively and reconstitution 
was achieved by injecting 3-5 ;K 106 syngeneic bone marrow ceils intravenously. After irradia- 
tion all mice were given polymyxin B  (100,000  IU/liter) and neomycin (10 rag/liter) in their 
drinking water. 
Antigens.--Fowl  immunoglobulin G  (F~/G) was obtained from chicken serum as described 
previously  (13).  Before iodination with  12sI (Radiochemical  Centre,  Amersham,  England, 
catalogue No. IMS 3), it was absorbed extensively against mouse lymphocytes to remove non- 
specific  anti-mouse  activity.  Human  gamma  globulin  (HGG)  was  provided  by  the  Com- 
monwealth Serum  Laboratories  as  a  solution containing  160  mg protein/ml.  Polymerized 
flagellin (IN)L) was prepared from the flagella of Salmonella adelaide by the method of Ada et 
al. (14). 
Preparalion of IodinaZed Antigens.--The antigens, F3~G, HGG,  and POL were iodinated 
with 125I, according to the method of Byrt and Ada (11).  Specific  activities of approximately 
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same number of labeled ceils if exposure times were adjusted appropriately. In the case of POL 
the specific activity was 3040 vCi/~g. F3,G-127I was prepared in a similar way except that a 
trace amount of F3+G-131I was used to monitor the iodination. For labeling of cells, the radio- 
active antigens were diluted in Dulbeeco's solution (8) containing 10% FCS and 1.5  X  10  -2 
~t sodium azide to a final concentration of 2 ~g/ml. Azide at this concentration did not interfere 
with the viability of lymphocytes, but did reduce nonspecific uptake of labeled antigen by 
phagocytic cells (11). 
Antisera.--Anfisera  to F3'G were obtained by immunizing mice with 500 ug alum-precipi- 
tated antigen (13) together with 2 X  109 killed  pertussis organisms (Commonwealth Serum 
Laboratories). 4--6 wk later, the mice were boosted with various amounts of fluid F3'G ranging 
from 1 to 100 vg and bled at intervals to provide pools of antisera of various titers. Each batch 
was heat inactivated at 56°C for ~  hr. Antibody levels were measured by a hemagglutination 
technique using sheep red  blood cells  (SRBC)  coated with fowl  anti-SRBC IgG  (13).  The 
method relies on the fact that chicken immunoglobulin does not fix mammalian complement 
(15). 
In one set of experiments antisera to POL and HGG were required. Anti-HGG antibody 
was prepared as described for anti-F3,G sera. Anti-flagellar sera were raised in rabbits and 
chickens as well as in mice. The former two were immunized with 500 s*g POL in complete 
Freund's adjuvant (Difco  Laboratories Inc., Detroit, Mich.) followed 3 wk later by a boost 
with 500  gg antigen in saline.  Blood was then collected between days 7 and 10 and the sera 
inactivated as mentioned previously. Mice received 20 ~g of POL in saline intraperitoneally 
on two occasions 4-6 wk apart and were then bled approximately 7 days after the second in- 
jection. Anti-HGG activity was assayed by microprecipitation (16) and anti-POL titers by the 
immobilization technique (14). When the effect of antisera from different sources was being 
compared, the dilutions were adjusted so that cells were exposed to comparable amounts of 
antibody activity. 
Incubation of Cells with Radioactively Labeled Antigen.--Suspensions  of lymphocytes pre- 
pared as described previously were divided into aliquots of 107 cells and centrifuged. To each 
cell button 400 ng of 125I-labeled antigen in 0.2 ml of Dulbecco's solution containing 10% FCS 
and sodium azide was added. After resuspension the mixture was incubated in an ice bath for 
30 min. Excess labeled antigen was then removed by centrifugation of the cells through 2-4 
FCS gradients. Smears for radioautography were made in 100% FCS on gelatin-coated slides. 
They were dipped in Kodak NTB2 emulsion, developed using D 19B, and stained with Giemsa. 
Clumped or damaged cells were ignored. Only cells carrying 10 or more grains were scored. 
Incubation of Cells with Antlbody.--Pretreatment  of cell suspensions with antibody before 
exposure to radioactive antigen was performed by incubating for 30 min at 37°C in the appro- 
priate dilution of antiserum. The suspension was then centrifuged, the supernatant removed, 
and the cell button either resuspended immediately in the antigen solution or washed through 
FCS gradients as described previously. 
Preparation of Isoantisera.--Anti-H-2  isoantisera were prepared by repeatedly injecting 
CBA and C57BL mice with lymphocytes  from C57BL and CBA donors, respectively, according 
to the schedule reported previously (7). Anti-0 C3H serum was raised in AKR mice by  the 
method of Reif and Allen (17). After separation from the clot, serum samples were inactivated 
at 56°C for 30 min and stored in small aliquots at --20°C until required. The potency of both 
types of isoantisera was tested by cytotoxicity against TDL from the appropriate strain, as 
described by Miller and Sprent (18). Guinea pig serum was used as a  source of complement. 
Control sera were obtained from normal CBA, C57BL, and AKR mice of comparable age and 
processed in identical fashion. 
RESULTS 
Binding  of Antibody  to Normal  Lymphocytes In  Vitro and In  Vivo.--TDL 
from  normal  mice  were  exposed  to  either  normal  mouse  serum  (NMS)  or BASTEN~  MILLER~  SPRENT~  AND  PYE  613 
hyperimmune anti-F3'G serum (titer 1 in 512) diluted 1 in  10 followed by the 
appropriate antigen, F~,G-125I (Table I). As expected, only occasional cells incu- 
bated in NMS  (approximately 1 in  104) bound antigen.  In contrast,  12-20% 
TDL labeled with the immune complex provided they were not washed after 
incubation with  antibody.  Labeling was  inhibited  by preincubation  of  anti- 
body-coated cells with excess F3,G-127I. When the assay was performed in the 
presence of 0.01  I  ethylenediaminetetraacetate (EDTA), which inhibits bind- 
ing of complexes to phagocytic cells (2), no diminution in labeling was observed. 
Repeated  washing  of  antibody-treated  cells  before  exposure  to  radioactive 
antigen greatly reduced the number of labeled cells (to less than 1%) (Table II). 
No decrease, however, was observed when the TDL were washed two to four 
times after reaction with F~/G-125I. These findings imply that the bond between 
TABLE  I 
Proportion of Normal Thoracic Duct Lymphocytes Binding Antibody Given In Vitro 
Pretreatment of TDL  Per cent labeled with FyG-~2~I 
NMS  <  1 
Anti-FyG serum  17  (12-20)* 
Anti-F3,G serum +  excess FTG- a~7I  <'1 
Anti-FTG serum +  0.01 M EDTA  16  (15-18)* 
* Results are expressed as arithmetic means of figures obtained from three to six experi- 
ments; range of values given in parenthesis. 
cell and antibody is weak but that the formation of the antibody-antigen com- 
plex on the cell surface stabilizes the bond at least at 4°C. 
When combinations other than anti-FTG-F3,G were tested, e.g. anti-HGG- 
HGG or anti-POL-POL,  similar results were obtained although insignificant 
binding  occurred if  an  antigen  not  corresponding to  the  antibody was  used 
(Table III). It can also be seen that antibodies to POL raised in rabbits and 
chickens bound  to mouse lymphocytes as  well  as  mouse  antibody,  provided 
the cells were incubated in antisera of similar potency. The ability of chicken 
anti-POL  to  adhere is  particularly interesting since  chicken immunoglobulin 
cannot fix mammalian  complement (15).  This point will  be referred to again 
during the discussion on complement requirements (6). 
To test whether antibody could attach to lymphocytes in vivo as well as in 
vitro,  normal  mice  were  passively  immunized  with  hyperimmune  anti-F3'G 
serum from the same pool used for the in vitro studies.  48 hr later the mice 
were cannulated and lymph was collected and centrifuged. The cell button was 
resuspended without further washing and the appropriate amount of radioac- 
tive antigen added immediately. Radioautographic examination revealed that 
17% TDL from these mice were labeled.  This was  identical to  the  figure ob~ 
tained in vitro (Table I). 
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Antibody.--TDL  from normal mice were incubated with  anti-F3'G antiserum 
of varying antibody titers  (ranging from 1:2  to  1:2056)  followed by F'FG-125I 
as  described  previously. As  shown  in  Table  IV,  the  number  of lymphocytes 
binding  radioactive  antigen  rose  with  increasing  antibody  levels  for  titers 
TABLE II 
Effect of Washing on Proportion of Normal  Thoracic Duct Lymphocytes Binding  Antibody 
In Vitro 
No. of washes 
Before exposure to  After exposure  to 
immune complexes  immune complexes 
Percentage of TDL labeled with anti-F~,G-F~,G-125I* 
% 
0  -  18 
1  -  2.4 
3  -  0.2 
5  -  0.1 
-  2  17 
3  15 
4  17 
* Figures obtained from one experiment. Two other experiments gave essentially the same 
results. 
TABLE III 
Capacity oj Different Combinations of Antibody and Antigen to Bind to Normal Tlwracic Duct 
Lymphocytes In Vitro 
Treatment of TDL 
Percentage labeled with* 
F~'G-I~r'I  HGG-12~I  POL-~I 
Normal serum s  < 1  < 1  < 1 
Anti-F3,G serum  12  (12-20)§  <1  <1 
Anti-HGG serum  <1  15  (12-19)  <1 
Mouse anti-POL  < 1  <: 1  15  (12-17) 
Rabbit anti-POL  16  (13-19) 
Chicken anti-POL  -  17  (12-21) 
* Figures obtained from two to six experiments. 
:~ Obtained  from normal mice, rabbits,  or chickens. In all cases < 1% TDL labeled with 
radioactive  antigen. 
§ Data from Table I. 
ranging  from  1  in  2  to  1  in  64,  for  the  exposure  time used.  When,  however, 
antisera of higher titer were used,  no further increase in labeled cells was ob- 
served.  Only  a  subpopulation  of lymphocytes thus  appears  to bind  antibody. 
Identification  of  the  Subpopulation  of  Lymphocytes  Binding  Antibody.- 
Mouse TDL  are  composed  of both  T  and  B  cells.  75-85%  have  the  charac- 
teristics of T  cells in  that  they are  susceptible to lysis with anti-0  serum and BASTEN,  MILLER~ SPRENT~ AND  PYE  615 
complement  (19).  Those lymphocytes with the capacity  to bind antibody  (12- 
20%) might  therefore be B  cells or a  subclass of T  cells. This was  investigated 
by using populations  of lymphocytes  enriched  for  either T  or  B  cells,  or  con- 
taining the two cell types in known numbers. The T  cell content was established 
with  well-characterized  markers  such  as  0  C3H  or  H-2  isoantigens  and  then 
compared  with  the  proportion  of cells binding antibody. 
TABLE  IV 
Relationship between Anti-FTG  Titer and the Number of TDL Binding F'yG-I~I 
Anti-F~,G titer  Per cent of TDL labeled with F~/G-~2~I  * 
% 
1:2  0.3 
1:8  2 
1:32  7 
1:64  14 
1:256  16 
1:2048  15 
* Results obtained from one particular experiment. Two  other experiments gave similar 
results. 
TABLE  V 
Sdective Binding of A ntlbody to B Lymphocytes 
Source of TDL  Per cent labeled with  Per cent killed by 
anti-F~,G-F-yG-~2~I  *  anti-0 C3H serum* 
Normal mice  16  (13-18)  80  (78-83) 
Athymic mice*  97  (95  98)  0 
FxBM mice  73  (66-83)  15  (12-17) 
Irradiated (CBA X  C57BL)F1 mice given  0.3  (0.1-0.5)  94  (90-98) 
CBA thymus cells (T.TDL) 
Normal mice after prolonged thoracic duct  45  (42-46)  50  (43-56) 
drainage 
TDL from normal mice following anti-0  75  (71-78)  - 
serum and C' 
* Results obtained from two to six experiments. 
:~ The heterozygotes (nu/+) were shown to possess the 8 C3H allele. 
Thoracic duct cannulation of athymic mice or adult thymectomized, irradiated, and mar- 
row-protected  (TxBM)  mice provided a source of lymphocytes markedly depleted of T  cells 
(B.TDL). A pure population of T  cells was obtained by the method of Sprent and Miller (20). 
For this purpose lethally irradiated (CBA X  C57BL)F1 mice were given 2 X  108 CBA thymus 
cells and cannulated 4  days later. The TDL  obtained were identified with anti-H-2 sera as 
CBA in origin and therefore derived from  the original thymus cell inoculum. They will be 
referred to as T.TDL. Populations of lymphocytes containing identifiable numbers of T  and B 
cells were obtained from chimeric donors prepared as described previously (21). CBA mice were 
neonatally thymectomized (NTx) and reconstituted to near normal immunological competence 
with repeated injections of (CBA X  C57BL)F1 thymus cells. Their TDL were composed of T 616  ANTIBODY  RECEPTOR  ON  B  LYMPIIOCYTES.  I 
cells, the great majority of which were derived from the FI thymus cell inoculum, and B cells 
of host (CBA) origin. The number of T and B cells present was then quantitated by cytotoxic 
assay (see Materials and Methods) with anti-C57BL serum and complement. 
Two groups of experiments were performed to identify the subpopulation of 
lymphocytes binding antibody. In the first, various types of lymphocytes, via. 
normal TDL, T.TDL, and B.TDL from both TxBM and athymic mice, were 
Fro. 1.  Photomicrograph  of thoracic duct lymphocytes  from athymic (nu/nu) mice after 
treatment with anti-F3'G'FTG-12aI. X 480. 
treated with either anti-0 C3H serum and complement or anti-FTG. F3~G-12aI. 
As shown in Table V anti4/serum killed approximately 80% of normal TDL, 
94 ,% of T.TDL, and 0% of B.TDL from athvmic mice. The immune complex, 
on the other hand, bound to 16~ of normal TDL, 97 ~  of B.TDL from athymic 
mice (Fig.  1), and 73% of TDL from TxBM mice but less than 1 oT/c. of T.TDL 
even after  exposure  of the  radioautographs for 60  days.  Furthermore,  T  cell 
depletion of normal mice by prolonged thoracic duct drainage and of normal 
TDL by in  vitro treatment with anti4 serum and cornplement, increased the 
proportion of lymphocytes binding antibody three- to fivefold (Table V). BASTEN,  MILLER,  SPRENT,  AND  PYE  617 
For the second set of experiments,  TDL were obtained from chimeric mice 
(NTx)  CBA reconstituted with  (CBA X  C57BL)F1 thymus cells. Their T  cell 
content was established  by estimating the number of lymphocytes susceptible 
to lysis with  anti-C57BL  serum  and  complement  and with  anti-0 serum  and 
complement  (Table  VI).  Treatment  of  the  same  cell  pools  with  anti-F3,G. 
F3,G-12~I resulted in 19 %  labeling.  Taken together  these findings strongly sug- 
gest that B  cells, not T  cells,  have a  receptor on their surface for antibody. 
Further evidence in support of this notion was sought by studying the effect 
of bursectomy on the number of antibody-binding lymphocytes in chickens. 
TABLE VI 
Evidence for Binding o/Antibody to B Lymphocytes 
Source of TDL  Per cent labeled with  Per cent killed by* 
anti-F'yG'F3'G-~2~I  CBA anti-C57BL  anti-0 
NTx CBA reconstituted  with  19  (17-22)  79  (76-80) 
(CBA X  C57BL)F1 thymus cells 
Normal CBA  17  (12-20):~  0 
69  (68-72) 
80  (75-84) 
* Results obtained from three experiments. 
:~ Data from Table I. 
Fertile eggs were obtained from outbred  White Leghorn chickens and incubated  at 38°C. 
Hormonal bursectomy was carried out on the llth day of incubation  by injection of 5 mg 
testosterone propionate  (Schering AG, Berlin) into the allantoic fluid (22). After hatching all 
birds were housed in cages and maintained on water and chick feed ad libitum. Blood was col- 
lected by venepuncture  at approximately 2 months of age and lymphocytes separated  as de- 
scribed previously (12). Bursectomized chickens without detectable circulating immunoglobulin 
were selected as donors. 
Cells from the latter and from nonbursectomized controls were reacted with 
normal  chicken  serum  (NCS)  or chicken  anti-POL  serum  followed  by POL- 
125I. Radioautography  revealed  that  only  occasional  cells  (< 1%)  incubated 
with  NCS  and  iodinated  antigen  were  labeled  (Table  VII). When  anti-POL 
serum was used,  this figure rose to a mean of 22 % in the case of control birds. 
In contrast, only 2-5 %  cells from bursectomized chickens bound antibody. 
Proportion of Small Mononuclear Cells Binding Antibody in Various Lymph- 
oid tissues.--If T  cells do indeed lack a receptor for antibody, an inverse rela- 
tionship  between  numbers  of antibody-binding mononuclear  cells  resembling 
small  lymphocytes and  of 0-positive  cells  would  be  expected  in  the  different 
lymphoid tissues.  Radioautographic examination revealed that only occasional 
thymus cells bound anti-F3,G. F3'GJ25I, whereas 40-45 %  splenic mononuclear 
cells,  20-25%  lymph  node  cells,  57-68%  Peyer's  patch  cells,  and  19-23% 
blood mononuclear cells did so (Table VIII). 
Distribution of Lymphocytes Binding Antibody.--Normal CBA mice were injected intrave- 
nously with 40 X  106 TDL from syngeneic donors. Before inoculation the cells were labeled 618  ANTIBODY  RECEPTOR  ON  B  LYMPHOCYTES.  I 
in vitro with anti-FTG. FTG-125I. The recipients were killed 1~, 4, 8, and 24 hr after injection 
and their spleens were removed and fixed in 10% formol saline. 5-/, sections were then prepared 
on gelatin-coated slides for radioautography and stained with methyl green-pyronin. 
Examination  of  sections  of  spleen  taken  1/,~ hr  after  injection  revealed  the 
presence  of  numerous  labeled  cells in  the  marginal  zones.  By  4  hr,  however 
TABLE  VII 
Frequency o/" Lymphocytes Binding Antibody in Blood from Normal and Bursectomized Chickens 
Source of lymphocytes*  Pretreatment  Per cent labeled with 
anti-POL.POL-l~I 
Normal  NCS  < 1 
anti-POL  22  (21-24j 
Bursectomized  NCS  < 1 
anti-POL  3.5  (2-5) 
* Obtained from eight normal and four bursectomized chickens. 
"FABLE VIII 
Proportion of Small Lymphocyte-Like Cells* Binding Antibody in  Various Mouse Lymphoid 
Tissues 
Tissue  Per cent labeled with anti-gyG.FyG-123I{: 
Thymus§  0.3  (0-1) 
Spleen  42  (40-45) 
Lymph node  21  (20-25) 
Thoracic duct lymph[]  17  (12-20) 
Peyer's patches  61  (58  67) 
Bone marrow¶  15  (12-17) 
Bone marrow  27  (21-33) 
Blood  19  (15-23) 
* Only small mononuclear cells were counted  because of the difficulty in distinguishing 
between nmnocytes and some lymphocytes. 
:~ Results obtained from two to four experiments. 
§ When  C57/6J  thymus  cells  were  examined  instead  of  CBA,  the  number  of  labeled 
lymphocytes rose to 24%. 
II Data from Table I. 
¶  Cells incubated with anti-FTG q- 0.01 M EDTA. 
very  few  ceils  with  attached  label  could  be  seen  anywhere.  This  was  due  to 
elution  of  radioactive  material  into  the  surrounding  white  pulp  where  it  was 
diffusely  scattered  presumably  on  dentritic  processes  of  macrophages.  The 
radioautographic  appearances  thus  resembled  those  of  previous  studies  on 
antigen localization (23).  In a  separate  experiment, labeled TDL  were injected 
into syngeneic mice with  an established  thoracic  duct fistula.  When  smears  of 
TDL  collected 12-48 hr later were examined,  no labeled cells were found.  This BASTEN~  ~v[ILLER, SPRENT,  AND  PYE  619 
complemented the previous observation  that  antigen eluted  from the injected 
l.~Tnphocytes soon after they had entered the lymphoid tissues. 
The  Relationship  between Antigen-Binding  Lymphocytes  and  Immunological 
Memory.--The ability of some lymphocytes to take up passively administered 
antibody in vivo  (vide supra)  made  it important  to test  whether  appreciable 
numbers of unwashed TDL from actively immunized mice would bind labeled 
antigen. 
For this purpose CBA mice were immunized with 500 t~g of alum-precipitated  FTG and 
2 X  109 killed pertussis organisms. 4-6 wk later  (at which time no antibody-forming cells to 
FTG were detectable in the lymph) TDL were collected and divided into two batches, one of 
which was washed one to eight times and the other left unwashed. Lymphocytes from both 
batches were reacted in vitro with FTG-12~I (for radioautography)  or F3,GI~I (for adoptive 
transfer). Those incubated with nonradioactive FTG were then counted and 5 X  106 cells in- 
TABLE IX 
Effect of Washing on Number of Labeled TDL from Mice Primed to FTG 
No. of washes before exposure  to labeled  antigen  Per cent TDL labeled  with F3,G-I~I * 
% 
0  17 
1  3 
3  0.6 
5  0.2 
8  28 
* Data obtained from one experiment. Five other experiments gave similar results. 
jected intravenously into heavily irradiated  syngeneic recipients. The antibody response was 
measured 7 days later by the Cunningham and Szenberg modification (24) of the Jerne plaque 
assay  (25). 
Primed TDL exposed to FTG-125I without either prior washing or addition of 
specific  antibody contained  17%  labeled  lymphocytes  (Table  IX).  Repeated 
washing,  however,  resulted  in  a  rapid  decline in  this  percentage  which,  even 
after  five washes  reached  neither  a  plateau  nor  the  level  found in  unprimed 
TDL (approximately 1 in 104). Further washing (e.g. eight times)  resulted in a 
nonspecific rise in antigen-binding cells presumably due  to damage to the cell 
membrane. 
The relationship between the presence of antibody on lymphocytes and their 
capacity to express memory was tested with TDL from various sources in an 
adoptive transfer system.  Unwashed  primed  TDL,  of which  1 in 5  to  1 in  6, 
bound  labeled  antibody-antigen  complexes,  and  thrice-washed  primed  TDL 
containing only 1 in 500 such  labeled cells, elicited an equally good 7S memory 
response when incubated with F3'G in vitro before transfer  (Table X).  It was 
therefore not surprising that irradiated recipients of unprimed TDL, incubated 
with anti-F3,G antiserum  and with or without antigen in vitro,  failed to show 620  ANTIBODY  RECEPTOR  ON  B  LYMPHOCYTES.  I 
significant antibody production. In other words immunological memory did not 
appear to depend on the presence of antibody on circulating lymphocytes. 
DISCUSSION 
B  lymphocytes differ from T  lyrnphocytes in  the  high density  of immuno- 
globulin on their surface  (19, 26)  and in the absence of the 0-alloantigen  (19). 
Neither  characteristic,  however,  provides  an  absolute  way  of  distinguishing 
them from T  cells. For example,  some T  cells may carry too little  0-antigen  to 
be  detectable  in  standard  assay  systems  (18).  Furthermore,  immunoglobulin 
has recently been detected on T  cells as well  as on B  cells by both direct  (27) 
and indirect techniques  (28). The demonstration of a distinctive marker for B 
TABLE X 
Rdationship  between Membrane-Associated Antibody  on  Lymphocytes and  their Capacity to 
Carry Immunological Memory 
Source of cells  No. of  Per cent TDL  Peak 7S F-~G PFC per spleen of 
washes  labeled with  irradiated recipients* 
F~,G-z2~I 
F'yG-primed TDL  0  18  215,200  (234,735-197,295) ~: 
F3,G-primed TDL  3  < 1  201,265  (220,175-183,981) 
Normal TDL  0  <1  21  (63-7):~ 
Normal TDL +  anti-FTG  0  16  92  (263-32):~ 
serum in vitro 
* F3,G given in vitro. Five to seven irradiated  hosts per group. 
:~ Geometric means, upper and lower limits of SE. 
cells was therefore desirable. Initially the mouse bone marrow-derived lympho- 
cyte antigen  (MBLA) antigen  (29)  appeared to fulfill this role, but conflicting 
reports of the  efficacy of anti-MBLA serum in specific elimination  of B  cells 
have now emerged.  2, a Until these inconsistencies have been reconciled and the 
extent  of contamination  of effective anti-MBLA serum with  antimacrophage 
or stem cell activity established,  the value of this marker remains limited. 
In the present communication, evidence has been advanced for the existence 
on all B  cells, but not on T  cells,  of a receptor for antibody. The receptor was 
detected by a radioautographic technique in which lymphocytes were incubated 
with antibody followed by the corresponding radioiodinated  antigen.  The ease 
with which antisera eluted with washing indicated that the bond between anti- 
body and cell was weak. The formation of an antibody-antigen complex on the 
surface, however,  stabilized  the bond and,  provided the  assay was performed 
2 Raft, M. C. Personal communication. 
3 Niederhuber, J. E., and E. M611er. 1971. Antigenic markers on mouse lymphoid cells: the 
presence of MBLA on antibody forming cells and antigen binding cells. Submitted for publica- 
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in  the cold, permitted accurate quantitation  of cells with  adherent antibody 
(Table II). Attachment of antibody to the lymphocyte required an intact Fc 
region as will be shown in a subsequent paper (6). Use of TDL and the failure 
of azide or EDTA to reduce the number of cells binding antibody tended to 
exclude significant labeling of macrophages or their precursors (Table I). The 
capacity of more  than  one  antibody-antigen complex to  adhere  to  the  cells 
established the nonspecificity of the phenomenon (Table III). 
Two approaches were adopted to show that this characteristic is a marker for 
B cells, not T cells. In the first, mouse lymphocyte populations greatly enriched 
for either T  or B  cells or containing T  and B cells in known proportions were 
used. The number of T  cells present was assessed by means of well-established 
markers namely 0 C3H antigen,  or H-2 antigen in the case of chimeric mice. 
This figure was then compared with the proportion of antibody-binding cells 
(Tables V  and VI).  In each instance,  an inverse relationship between T  cells 
and  antibody-binding cells  was  observed which was  particularly striking  for 
TDL from athymic mice;  97%  labeled  with  an immune  complex, but none 
were ~9 positive. The variability in numbers of labeled TDL from TxBM mice 
was at first sight disturbing; however, electron microscope studies of these cells 
(6)  revealed that up to 25 %  had  the features characteristic of plasma  cells, 
none of which bound antibody. Examination of the effect of bursectomy in the 
chicken provided a second approach to identification of the type of lymphocyte 
carrying this receptor. The frequency of antibody-binding cells among blood 
lymphocytes of  bursectolnized  birds  was  remarkably  reduced  (Table  VII). 
Since these birds have negligible quantities of circulating immunoglobulin pre- 
smnably due to a deficiency in B cells, and yet are capable of mounting normal 
delayed hypersensitivity responses (22), these findings, together with those in 
the mouse, strongly suggest that B cells, not T  cells, bind antibody. 
The proportion of antibody-binding cells from various  sources other  than 
thoracic duct lymph was estimated and expressed as a percentage of the total 
number  of  small  lymphocyte-like cells present.  When  these  percentages  are 
compared with reported figures for P-positive cells in the same tissues, an inverse 
relationship is obtained for spleen, lymph node, thymus, Peyer's patches, and 
blood (19). Examination of small mononuclear cells from bone marrow revealed 
that approximately 15 % labeled, provided the antiserum used was pretreated 
with EDTA to minimize binding to phagocytic cells. In the absence of EDTA 
the number of cells  binding antibody increased to a  mean of 27%.  Thus the 
~bility of effective anti-MBLA serum to kill up to 60% of bone marrow cells  3 
implies that it must possess nonspecific activity against cell types other than B 
lymphocytes. 
Adherence  of immune  complexes  to  some  lymphocytes had  been  demon- 
strated previously (1, 2), but the establishment of this property as a marker for 
all  B  lymphocytes had not.  For example, complexes in the form  of antibody- 
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(complement receptor lymphocytes, [CRL])  with  B  cells,  but not with T  cells 
(3,  4).  However,  only  a  minority  of lymphocytes from  th}~nectomized  mice 
(e.g.  40-45%  lymph node ceils)  displayed this ability  (3).  Two possible  inter- 
pretations of the data suggest themselves; either CRL  represent a  subpopula- 
tion of B  ceils or the sensitivity of the technique does  not  permit  detection of 
those lymphocytes with receptors of lower avidity.  Evidence for the  latter  in- 
terpretation stems from recent experiments in which  B  cell  rosettes  were ob- 
tained in the absence of complement, provided the erythrocytes were sensitized 
bv  isologous  antibody  rather  than  heterologous  antibodyJ  In  other  words 
C'3 may simply have acted as an  adjuvant to rosette formation. Furthermore, 
binding in our system in which soluble, not particulate, antigens were employed 
occurred with isologous or heterologous antibody  and in the  absence of com- 
plement (6). It is therefore reasonable to suggest that both methods detect the 
same type of receptor but with different degrees of sensitivity. 
The existence of a marker of this kind for all B cells has permitted the devel- 
opment of a method for selectively depleting mixed lymphocyte populations of 
their  B  cell  content  (5).  Plastic  beads coated with  an  antigen  such  as HGG 
were  poured  into  columns.  Mouse  lymphoid  cells  from spleen  and  thoracic 
duct were incubated with the corresponding antibody and then passed through 
the column. As predicted, B  ceils were retained while T  ceils were excluded. T 
cells obtained in  this way have proved of considerable value in both in vivo 
and in vitro studies of T-B cell interaction. Furthermore, the demonstration of 
a subpopulation of human lymphoid cells with the capacity to bind antibody 
(5)  may provide a way of separating T  cells in man. 
The fact that B lymphocytes have receptors on their surface for the Fc por- 
tion of antibody molecules as well as immunoglobulin receptors (19,  26)  neces- 
sitates care in interpretation of antigen-binding studies particularly when ceils 
from immunized animals are being used or when cross-reacting antibody might 
be present. It will be recalled that repeated washing of primed TDL (Table IX) 
before exposure to radioactive antigen,  resulted in a  rapid decline in the per- 
centage of labeled cells. This figure, however, never reached a plateau even after 
five centrifugations while further washing resulted in progressive damage to the 
cell membrane and a nonspecific rise in antigen-binding cells.  In our hands at 
least, it was not possible to establish, with this technique, whether a lymphocyte 
population  carrying  memory  to  a  particular  antigen  was  enriched  for  ceils 
specifically binding that antigen. 
Modabber and Sercarz  (30)  using a different assay system have also shown 
that the increase in antigen-binding ceils detectable in primed animals can be 
explained  in  terms  of cytophilic  antibody.  They did  not,  however,  correlate 
their  findings  with  the  capacity  of lylnphocytes  to  carry memory. We  have 
4 Cline, M. J., J. Sprent, N. L. Warner, and A. W. Harris. 1971. Receptors for immuno- 
globulin on B lymphocytes and cells of a cultmed plasma cell tumor. Submitted for publication. BASTEN,  MILLER~ SPRENT,  AND  PYE  623 
tested this possibility in an adoptive transfer system by comparing the anti- 
body response of TDL from primed mice washed zero to three times with that 
of normal TDL either coated or not coated with antibody (Table X). The results 
showed clearly that immunological memory is not related to cytophilic binding 
of antibody to B  cells. 
The precise physiological significance of this receptor has not been established. 
Some workers have already suggested that B  cells as well as dendritic macro- 
phages may play a role in antigen localization particularly during a secondary 
response when antibody is already present in the system (2,  31).  Support for 
this possibility stems from our own studies  (32)  which utilized the ability of 
antibody-coated B cells to carry antigen into the spleen where, as shown here, 
it eluted rapidly into the surrounding white pulp. Opsonization of cells did not 
occur  presumably  because  insignificant  amounts  of  complement  were  fixed 
during binding. In these experiments B cells from TxBM donors were coated with 
the haptenic determinant, NIP, in the form of anti-F3,G. F3'G. NIP10 complexes. 
If they were washed  to  remove excess antigen  and  then  transferred into ir- 
radiated  hosts  together  with  NIP-HGG  primed  spleen  cells,  as  a  source of 
hapten-sensitive cells, an excellent anti-NIP antibody response ensued without 
further addition of antigen. In other words NIP was concentrated so effectively 
in the spleen that overriding of the carrier effect was achieved with very low 
doses of antigen. Experiments with this system are in progress to examine the 
effect of using a more highly substituted NIP conjugate. It is possible that a 
sufficiently high epitope density may be achieved in the microenvironment of 
the B  cell  to induce a  state  of tolerance rather than immunity  (33).  If that 
should prove to be the case, the receptor on B cells for the Fc fragment of the 
antibody molecule could possibly play a role in the genesis of in vivo antibody- 
mediated suppression (34,  35) or in vitro antibody-mediated tolerance (33). 
The capacity of B cells to bind antibody in the absence of complement may 
in  addition  provide a  rational  explanation for antibody-dependent killing of 
target cells by nonsensitized lymphoid cells (36, 37). Here anti-target antibody 
which is known to inhibit the cytotoxic activity of T  cells  (38)  would enhance 
contact between target ceils and B cells thereby permitting killing by the latter. 
This notion is supported by recent evidence establishing that spleen cells from 
rats subjected to either prolonged thoracic duct drainage (39)  or thymectomy 
(40)  can still exert a cytotoxic effect. 
SUMMARY 
Evidence is presented for the existence on all B lymphocytes, but not on T 
lymphocytes, of a  membrane-associated  receptor for antibody.  The receptor 
was  detected by a  radioautographic technique in  which  lymphoid cells were 
incubated with antibody followed by the corresponding radioiodinated antigen. 
The ease with which antibody eluted during washing indicated that the bond 
between antibody and  cell was weak.  The formation of an  antibody-antigen 624  ANTIBODY  RECEPTOR  ON  B  LYMPHOCYTES.  I 
complex  on the  cell  surface,  however,  stabilized  the  bond  and  permitted  ac- 
curate quantitation  of cells with adherent antibody. 
The ability of several combinations of antibody and antigen to adhere to the 
cells demonstrated  the nonspecificity of the phenomenon and emphasized  the 
need  for  care  in  interpretation  of  antigen-binding  studies  particularly  when 
immune cells are being used. 
The identity,  of antibody-binding lymphocytes was  established  by two dif- 
ferent approaches. In the first, mouse lymphocyte populations greatly enriched 
for either T  cells or B cells were examined. Their T  cell content was assessed by 
means of well-established markers such as the 0 C3H isoantigen. When this was 
compared with  the  number  of antibody-binding cells,  an inverse  relationship 
was obtained in each instance; thus almost all thoracic duct cells from athymic 
mice labeled with an inmmne complex although none were 0 positive.  The strik- 
ing reduction in antibody-binding cells observed in bursectomized chickens pro- 
vided a second and independent line of evidence suggesting that  B  cells, not T 
cells, bind antibody. 
The ability of B  cells from primed animals to bind antibody in vivo made it 
important  to  test  whether  this  phenomenon  was  related  to  the  carriage  of 
immunological  memory.  No  correlation  was,  however,  found  between  mem- 
brane-bound antibody and memory. 
It was proposed  that  the  existence  of a  receptor  of this  kind  may provide 
a  rational  explanation  for antibody-dependent  killing of target cells  and may 
prove of importance in antigen concentration particularly during the secondary 
response. 
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